A huge early milestone! Credit to our members who have fed into this project as it has developed and to the Genomics England team for prioritising the contribution of the rare community. Genetic Alliance UK is a proud partner in the all important evaluation of this study.

The start of this project, The Generation Study, is a milestone in medicine because we will start to uncover a wide range of genetic conditions at birth--and learn how to treat them.

We welcome today's announcement from Health and Social Care Secretary, Wes Streeting on improving access to primary care data for research. This will help to advance healthcare and research innovation. Hear from our CEO Rich Scott👇 Richard Scott Wes Streeting

“Combining genomic data with primary care records would create a rich dataset essential for unlocking the full potential of research” The Participant Panel share their thoughts on Health & Social Care Secretary announcement on improving access to primary care data for research👇

Last week Genomics England with NHS Genomic Medicine Service launched the generation study (great quotes from Head of NHS Amanda Pritchard+UK Health Secretary of State Wes Streeting)- whole genome sequencing of 100,000 babies to see if early diagnosis of ~200 diseases would be useful for healthcare

👉 Out now Nature Reviews Genetics: we CAN and we SHOULD do more to enable #genomic data sharing! 🧬🌏 👉Best practice examples and 12 actions we can all take together 👉 rdcu.be/dWfsu GA4GH Australian Genomics Genomics England NHS Genomic Medicine Service AllofUsResearch UK Biobank Our Future Health

The first newborns have been tested for 200+ rare genetic conditions as Genomics England embarks on its Generation Study. Dr Charlott Repschläger writes more about this revolutionary study in BioNews: progress.org.uk/first-newborns…

Our UK alliance shared their focus on keeping rare diseases on the agenda with a new government. ✊ Genetic Alliance UK They've made major strides in genomics, including the 100,000 Genomes Project and the Generation Study, trialling newborn screening via genome sequencing. 🧬

⬇️Our Policy Director, Nick Meade, representing at EURORDIS-Rare Diseases Europe #CNA Council of National Alliances and sharing both challenges and areas of progress. Learn more about what we do and how we do it geneticalliance.org.uk

Today the government announced a new partnership with Oxford Nanopore designed to enable genomics-based research and bring the benefits of innovative technologies to patients. We are proud to be part of it. Find out more: ow.ly/XtoA50U0fQi Oxford Nanopore

A Cancer Grand Challenges project including researchers from the Crick, UCL News and Genomics England has shown that rogue genetic material called ecDNA could potentially be targeted to improve responses to cancer therapies crick.ac.uk/news/2024-11-0…